Skip to main content

Health economic modeling for medical technologies in Europe

Early and comprehensive economic models to determine economic value proposition and inform healthcare decision-makers

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Funding of 500 million DKK for home treatment with digital solutions in Denmark

In December 2023, the Government, Danish Regions, and Municipalities (KL) signed an agreement providing 500 million DKK from 2023 to 2028 to support digital home treatment in the healthcare system.

Funding will support the following five targets:

  • The number of physical checks at hospitals for patients with chronic obstructive pulmonary disease (COPD), diabetes, and heart failure will be reduced by half as the result of switching to continuous digital monitoring in their own homes and virtual contacts;
  • The number of digital courses for people with mental unhappiness will be doubled;
  • Patients in all municipalities will be offered digital rehabilitation courses and digital screen visits in nursing
  • Video consultations continue to spread in general practice, and the proportion of total consultations increases year by year in the period.

The agreement confirms funding for the trial scheme for type 2 diabetes in 2024-2026, in which selected patients (up to 4,400) will be offered sensor-based glucose monitoring (CGM/FGM). Furthermore, in 2025, up to 1,400 COPD patients will be provided non-invasive ventilation (NIV) at home.

See more information in Danish here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.